Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05620979 · ClinicalTrials.gov registry record · NA

Financial Navigation Study Among Young Adult Blood Cancer Survivors

A NA study of Cancer and Survivorship, sponsored by Tufts Medical Center.

Completed
Registry status
NA
Development phase
130
Enrollment target
5
Study locations

NCT05620979: Completed NA study of Cancer and Survivorship, sponsored by Tufts Medical Center.

NCT05620979 is a NA study of Cancer and Survivorship that has completed, run by Tufts Medical Center. The registered enrollment target is 130 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05620979, a NA study of Cancer and Survivorship, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
5
Study locations

Study Summary

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

Primary Outcome

To evaluate the change in financial distress associated with randomization group assignment from baseline to 6-month follow up as measured by the 8-item Personal Financial Wellness Scale (PFW). The PFW scores range from 1-10 where lower scores indicate greater financial distress.

Interventions

  • BEHAVIORAL Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.

Study Locations (5)

California

  • Children's Hospital Los Angeles - Los Angeles
  • University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital) - Los Angeles

Massachusetts

  • Tufts Medical Center - Boston

South Carolina

  • Bon Secours Mercy Health System - Greenville

Texas

  • MD Anderson - Houston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2022-02-14
Est. Completion 2023-11-23
Phase NA
Tufts Medical Center

169 total trials

What the finished NCT05620979 record still lists

NCT05620979 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation. is the first listed.

NCT05620979 lists 5 locations in 4 states (California, Massachusetts, South Carolina).

Frequently Asked Questions

What is clinical trial NCT05620979 about?

NCT05620979 is a clinical study titled "Financial Navigation Study Among Young Adult Blood Cancer Survivors". Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview...

What is the current status of trial NCT05620979?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-02-14. Estimated completion is 2023-11-23.

What conditions does trial NCT05620979 study?

This clinical trial studies the following conditions: Cancer, Survivorship, Financial Stress.

What interventions are being tested in trial NCT05620979?

The interventions under investigation include: Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05620979?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05620979 being conducted?

This trial has 5 study locations across California, Massachusetts, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05620979's enrollment target sits among peer trials

130 277th of 615 higher than 336 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

  • NCT02708836 · 130 participants · NA

    Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05620979, the US trial registry maintained by the National Library of Medicine. NCT05620979 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.